Pharmacotherapeutic Options for Type 2 Diabetes Patients with HFrEF
Jack Wei Chieh Tan, David Sim, Junya Ako, Wael Almahmeed, Mark E Cooper, Jamshed Dalal, Chaicharn Deerochanawong, David Wei Chun Huang, Sofian Johar, Upendra Kaul, Sin Gon Kim, Natalie Koh, Alice Pik-Shan Kong, Rungroj Krittayaphong, Bernard Kwok, Bien J Matawaran, Quang Ngoc Nguyen, Loke Meng Ong, Jin Joo Park, Yongde Peng, David Quek, Ketut Suastika, Norlela Sukor, Boon Wee Teo, Chee Kiang Teoh, Jian Zhang, Eugenio B Reyes, Su Yen Goh
Citation:European Cardiology Review 2021;16:e14.